Weight management
Pfizer to end development of experimental obesity pill due to elevated liver enzymes
Pavlo Gonchar | Lightrocket | Getty Images Pfizer on Monday said it would stop developing its experimental obesity and diabetes pill, lotiglipron, due to elevated liver enzymes in patients who took the drug once a day in mid-stage clinical studies. Those elevated enzymes often indicate damage to cells in the liver, but the pharmaceutical giant […]
Read More
Obesity is a chronic disease. It’s why treating it will be so profitable unless payers push back
While there has been plenty of buzz about how successful patients have been in losing weight while taking a new class of obesity medications, there is a growing realization that when people stop taking these pricey drugs, the pounds can creep back on. There was a frank discussion of this on Eli Lilly’s first-quarter earnings […]
Read More
Credit score Suisse upgrades Novo Nordisk on ‘surprise’ advancement of weight problems and diabetic issues prescription drugs Ozempic and Wegovy
Credit history Suisse upgraded Danish pharmaceutical firm Novo Nordisk to outperform from neutral on Thursday, citing expansion in its weight problems and diabetes medications. Body weight-reduction drug Wegovy has experienced a profitable relaunch soon after working with supply issues, when diabetes drug Ozempic has witnessed accelerating advancement as a substitute of moderation following Wegovy’s relaunch, […]
Read More
Trending billionaire and celeb GLP-1 pounds loss medication are about to enter far more American houses
Working with GLP-1s drug injections for bodyweight decline has come to be one particular of the most up-to-date techniques some major names in the market place are shedding further lbs. Elon Musk just lately tweeted about how employing Novo Nordisk’s Wegovy assisted him shed excess weight. Fanatics CEO Michael Rubin just lately instructed CNBC’s “Squawk […]
Read More